Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, ...

Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how ...

A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

The current prostate-specific antigen (PSA) test’s tendency to over-diagnose patients who would have lived happily without needing treatment has meant that officials have resisted calls for a ...

The current prostate-specific antigen (PSA) test is a blood test which is used to check for prostate conditions including prostate cancer or an enlarged prostate, but not routinely offered because ...

the percentage found to have clinically significant disease was higher than the percentage that would have been identified with the use of prostate-specific antigen (PSA) or MRI screening ...

The prostate-specific antigen (PSA) test is a blood test which is used to check for prostate conditions including prostate cancer or an enlarged prostate. Routine PSA testing is not currently offered ...

Forbes contributors publish independent expert analyses and insights. I am a Forbes contributor covering travel, wellness and beauty. Prostate cancer is the second most common cancer among men in ...

The α2,3-sialyl N-glycosylated free prostate-specific antigen ratio (S2,3PSA%) was approved in Japan as a prostate cancer (PCa) diagnostic test. We evaluated the analytical characterization and ...